Niedzika Camacho

4PUBLICATIONS
72CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.

Harveer Dev, Mark Linch, Krishna Narahari

|Feb 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

Jonathan Mitchell, Niedzica Camacho, Patrick Shea

|Feb 03, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors.

Ping Chi, Li-Xuan Qin, Niedzica Camacho

|Sep 26, 2017
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

Niedzica Camacho, Peter Van Loo, Sandra Edwards

Pageof 1